127 related articles for article (PubMed ID: 8890720)
1. Hyperprolactinaemia is associated with a higher prevalence of pituitary-adrenal dysfunction in non-functioning pituitary macroadenoma.
Tjeerdsma G; Sluiter WJ; Hew JM; Molenaar WM; de Lange WE; Dullaart RP
Eur J Endocrinol; 1996 Sep; 135(3):299-308. PubMed ID: 8890720
[TBL] [Abstract][Full Text] [Related]
2. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia.
Beentjes JA; Tjeerdsma G; Sluiter WJ; Dullaart RP
Clin Endocrinol (Oxf); 1996 Oct; 45(4):391-8. PubMed ID: 8959076
[TBL] [Abstract][Full Text] [Related]
3. The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery.
Courtney CH; McAllister AS; McCance DR; Hadden DR; Leslie H; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2000 Sep; 53(3):309-12. PubMed ID: 10971447
[TBL] [Abstract][Full Text] [Related]
4. Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis.
Courtney CH; McAllister AS; McCance DR; Bell PM; Hadden DR; Leslie H; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):431-6. PubMed ID: 11012567
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of adrenal function in patients with hypothalamic and pituitary disorders: comparison of serum cortisol, urinary free cortisol and the human-corticotrophin releasing hormone test with the insulin tolerance test.
Dullaart RP; Pasterkamp SH; Beentjes JA; Sluiter WJ
Clin Endocrinol (Oxf); 1999 Apr; 50(4):465-71. PubMed ID: 10468905
[TBL] [Abstract][Full Text] [Related]
6. The assessment of the functional capacity of the hypothalamic-pituitary-adrenal axis by measurement of basal plasma and urinary cortisol in comparison with insulin-induced hypoglycaemia and metyrapone tests.
de Lange WE; Sluiter WJ
Neth J Med; 1993 Aug; 43(1-2):64-8. PubMed ID: 8232696
[TBL] [Abstract][Full Text] [Related]
7. Plasma 11-deoxycortisol, androstenedione, testosterone and ACTH in comparison with the urinary excretion of tetrahydro-11-deoxycortisol as indices of the pituitary-adrenal response to oral metyrapone.
de Lange WE; Sluiter WJ; Pratt JJ; Doorenbos H
Acta Endocrinol (Copenh); 1980 Apr; 93(4):488-94. PubMed ID: 6247869
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone and prolactin are secreted more irregularly in patients with Cushing's disease.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
Clin Endocrinol (Oxf); 2000 May; 52(5):625-32. PubMed ID: 10792343
[TBL] [Abstract][Full Text] [Related]
9. Cut-off values for sufficient cortisol response to low dose Short Synacthen Test after surgery for non-functioning pituitary adenoma.
Kolnes AJ; Øystese KA; Dahlberg D; Berg-Johnsen J; Niehusmann P; Pahnke J; Bollerslev J; Jørgensen AP
Acta Neurochir (Wien); 2020 Apr; 162(4):845-852. PubMed ID: 31907611
[TBL] [Abstract][Full Text] [Related]
10. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis.
Fiad TM; Kirby JM; Cunningham SK; McKenna TJ
Clin Endocrinol (Oxf); 1994 May; 40(5):603-9. PubMed ID: 8013141
[TBL] [Abstract][Full Text] [Related]
11. Standard and low-dose short adrenocorticotropin test compared with insulin-induced hypoglycemia for assessment of the hypothalamic-pituitary-adrenal axis in children with idiopathic multiple pituitary hormone deficiencies.
Weintrob N; Sprecher E; Josefsberg Z; Weininger C; Aurbach-Klipper Y; Lazard D; Karp M; Pertzelan A
J Clin Endocrinol Metab; 1998 Jan; 83(1):88-92. PubMed ID: 9435421
[TBL] [Abstract][Full Text] [Related]
12. Reduced epinephrine reserve in response to insulin-induced hypoglycemia in patients with pituitary adenoma.
Morita S; Otsuki M; Izumi M; Asanuma N; Izumoto S; Saitoh Y; Yoshimine T; Kasayama S
Eur J Endocrinol; 2007 Sep; 157(3):265-70. PubMed ID: 17766707
[TBL] [Abstract][Full Text] [Related]
13. Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea.
Genazzani AD; Bersi C; Luisi S; Fruzzetti F; Malavasi B; Luisi M; Petraglia F; Genazzani AR
J Steroid Biochem Mol Biol; 2001 Sep; 78(3):247-52. PubMed ID: 11595505
[TBL] [Abstract][Full Text] [Related]
14. [Hypothalamic-pituitary-adrenal function in primary hypothyroidism].
Bakiri F; Benmiloud M
Presse Med; 1994 Feb; 23(7):320-4. PubMed ID: 8208691
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
[TBL] [Abstract][Full Text] [Related]
16. Are prolactin levels efficient in predicting a pituitary lesion in patients with hyperprolactinemia?
Varaldo E; Cuboni D; Prencipe N; Aversa LS; Sibilla M; Bioletto F; Berton AM; Gasco V; Ghigo E; Grottoli S
Endocrine; 2024 May; 84(2):670-676. PubMed ID: 38194218
[TBL] [Abstract][Full Text] [Related]
17. Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function.
Kamilaris TC; DeBold CR; Pavlou SN; Island DP; Hoursanidis A; Orth DN
J Clin Endocrinol Metab; 1987 Nov; 65(5):994-9. PubMed ID: 3499449
[TBL] [Abstract][Full Text] [Related]
18. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma.
Fernández-Real JM; Engel WR; Simó R; Salinas I; Webb SM
Clin Endocrinol (Oxf); 1998 Jul; 49(1):53-61. PubMed ID: 9797847
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
[TBL] [Abstract][Full Text] [Related]
20. Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery?
Auchus RJ; Shewbridge RK; Shepherd MD
Clin Endocrinol (Oxf); 1997 Jan; 46(1):21-7. PubMed ID: 9059554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
